NIH-funded research U01 cooperative agreement

Genes that affect how people respond to cocaine

Official title: Genetics of Cocaine Sensitivity in Drosophila

Funded at Clemson University · NIH-11323965 · Data updated 2026-11-12

Using fruit flies to find genes that may change how people react to cocaine and to inform future treatments for addiction.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionClemson University
NIH-funded
Lab location1 site (Clemson, United States)
Project startSeptember 15, 2017
Project endApril 30, 2027
Funding year2026
Award (this year)$495,376
NIH project number5U01DA041613-10
Project IDNIH-11323965 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people affected by cocaine use disorder or individuals at high risk who might benefit from gene-informed prevention or treatments in the future.

Less likely to help

People seeking immediate clinical treatment or whose substance use is driven mainly by social or environmental factors are unlikely to get direct benefit from this lab-based work.

What this research studies

Scientists use fruit flies because many fly genes mirror human genes, letting researchers study genetic effects quickly and cheaply. They screen a large set of inbred fly strains and use genetic tools such as CRISPR to pinpoint variants that change fly behavior after cocaine exposure. By linking specific genes to drug sensitivity in flies, investigators hope to identify human-relevant genes and pathways. Those findings could guide later human studies and new treatment strategies.

Why it matters

Potential benefit: Could point to human genes or pathways that lead to better-targeted treatments or prevention strategies for cocaine addiction.

How similar studies have gone: Previous fruit-fly research has successfully identified genes that influence responses to stimulants, but turning those findings into proven human therapies remains largely untested.

Where this research is happening

  • Clemson University
    Clemson, United States
    Active

Researchers

  • Principal investigator: Mackay, Trudy F. — Clemson University
  • Study coordinator: Mackay, Trudy F.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.